Search results for "3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors"

showing 1 items of 1 documents

PLTP activity is a risk factor for subsequent cardiovascular events in CAD patients under statin therapy: the AtheroGene study.

2009

Phospholipid transferprotein (PLTP) mediates both net transfer and exchange of phospholipids between different lipoproteins. Although many studies have investigated the role of PLTP in atherogenesis, the role of PLTP in atherosclerotic diseases is unclear. We investigated the association of serum PLTP activity with the incidence of a combined endpoint (myocardial infarction and cardiovascular death) and its relation to other markers of atherosclerosis in 1,085 patients with angiographically documented coronary artery disease (CAD). In the median follow-up of 5.1 years, 156 patients had suffered from the combined endpoint of myocardial infarction or cardiovascular death including 47 of 395 p…

Malemedicine.medical_specialtyMyocardial InfarctionQD415-436Coronary Artery DiseaseKaplan-Meier Estimatelipid transfer proteinsBiochemistryCoronary artery diseasechemistry.chemical_compoundEndocrinologyRisk FactorsInternal medicinePhospholipid transfer proteinmedicineHumansMyocardial infarctionRisk factorPhospholipid Transfer Proteins3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitorsAgedCholesterolbusiness.industryProportional hazards modelConfoundingCase-control studyCell BiologyMiddle Agedmedicine.diseaseAtherosclerosisPrognosisEndocrinologychemistryCase-Control StudiesCardiologyFemaleHydroxymethylglutaryl-CoA Reductase InhibitorsbusinessPatient-Oriented and Epidemiological ResearchFollow-Up StudiesJournal of lipid research
researchProduct